Holen Sie sich die Stockscreener-App
77.29
2.98%
2.24
Handel nachbörslich:
77.10
-0.19
-0.25%
Schlusskurs vom Vortag:
$75.05
Offen:
$75.1
24-Stunden-Volumen:
542.86K
Relative Volume:
0.67
Marktkapitalisierung:
$8.13B
Einnahmen:
$628.56M
Nettoeinkommen (Verlust:
$141.82M
KGV:
61.34
EPS:
1.26
Netto-Cashflow:
$142.60M
1W Leistung:
+2.32%
1M Leistung:
+2.52%
6M Leistung:
+1.97%
1J Leistung:
+38.22%
1-Tages-Spanne:
$74.93
$78.98
1-Wochen-Bereich:
$73.79
$78.99
52-Wochen-Spanne:
$49.00
$117.33
Corcept Therapeutics Inc Stock (CORT) Company Profile
Firmenname
Corcept Therapeutics Inc
Sektor
Branche
Telefon
650.688.8803
Adresse
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Vergleichen Sie CORT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CORT
Corcept Therapeutics Inc
|
77.29 | 7.89B | 628.56M | 141.82M | 142.60M | 1.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Corcept Therapeutics Inc Stock (CORT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-18 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-11-06 | Hochstufung | Truist | Hold → Buy |
| 2023-04-11 | Eingeleitet | SVB Securities | Market Perform |
| 2023-04-04 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-15 | Herabstufung | Jefferies | Buy → Hold |
| 2022-08-01 | Herabstufung | Truist | Buy → Hold |
| 2022-07-27 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-27 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-02-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-01-28 | Eingeleitet | Truist | Buy |
| 2020-08-05 | Herabstufung | Jefferies | Buy → Hold |
| 2019-09-24 | Eingeleitet | Jefferies | Buy |
| 2019-09-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-02-04 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2018-08-10 | Bestätigt | Stifel | Hold |
| 2018-05-31 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-09 | Eingeleitet | B. Riley FBR, Inc. | Buy |
| 2017-08-31 | Eingeleitet | Stifel | Buy |
| 2017-02-02 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2015-04-21 | Eingeleitet | FBR Capital | Outperform |
| 2014-01-13 | Herabstufung | Stifel | Buy → Hold |
| 2013-08-09 | Herabstufung | Janney | Buy → Neutral |
| 2013-08-09 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2012-02-21 | Bestätigt | JMP Securities | Mkt Outperform |
| 2010-01-06 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2008-07-17 | Eingeleitet | Rodman & Renshaw | Mkt Outperform |
| 2007-06-21 | Hochstufung | Punk, Ziegel & Co | Mkt Perform → Accumulate |
Alle ansehen
Corcept Therapeutics Inc Aktie (CORT) Neueste Nachrichten
Will Corcept Therapeutics Incorporated stock continue upward momentum - newser.com
Will Corcept Therapeutics Incorporated stock remain a Wall Street favorite - newser.com
Why Corcept Therapeutics Incorporated stock is a value investor pickPortfolio Update Report & Expert Curated Trade Ideas - newser.com
Will Corcept Therapeutics Incorporated stock recover after recent drop2025 Fundamental Recap & AI Powered Trade Plan Recommendations - newser.com
Is Corcept Therapeutics Incorporated (HTD) stock inflation resilient2025 Market Outlook & Fast Exit and Entry Strategy Plans - newser.com
Does Corcept Therapeutics Incorporated (HTD) stock trade below intrinsic valueJuly 2025 PostEarnings & Real-Time Volume Analysis - newser.com
Why Corcept Therapeutics Incorporated (HTD) stock is a must watch tickerMarket Performance Report & Expert Approved Momentum Trade Ideas - newser.com
Will a bounce in Corcept Therapeutics Incorporated offer an exitWeekly Trend Summary & Safe Entry Trade Signal Reports - newser.com
How Corcept Therapeutics Incorporated stock compares to growth peersJuly 2025 Momentum & Safe Capital Growth Trade Ideas - newser.com
How high can Corcept Therapeutics Incorporated stock goWeekly Trend Report & Weekly Setup with ROI Potential - newser.com
Is Corcept Therapeutics Incorporated (HTD) stock undervalued at current priceQuarterly Portfolio Report & Safe Investment Capital Preservation Plans - newser.com
Does Corcept Therapeutics Incorporated qualify in momentum factor screeningJuly 2025 Breakouts & Smart Money Movement Tracker - newser.com
What Does Wall Street Think About Corcept Therapeutics (CORT)? - MSN
Key metrics from Corcept Therapeutics Incorporated’s quarterly dataMarket Activity Report & AI Driven Stock Reports - newser.com
Will Corcept Therapeutics Incorporated (HTD) stock return to pre crash levelsPortfolio Update Report & Long-Term Safe Investment Plans - newser.com
Total assets of Corcept Therapeutics Incorporated. – HAM:HTD - TradingView
What indicators show strength in Corcept Therapeutics IncorporatedJuly 2025 Sentiment & Free Risk Controlled Daily Trade Plans - newser.com
Wolfe Research Initiates Coverage of Corcept Therapeutics (CORT) with Peer Perform Recommendation - Nasdaq
Corcept Therapeutics Inc (HTD.DU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Wolfe Research Initiates Coverage on Corcept Therapeutics (CORT) with "Peer Perform" Rating | CORT Stock News - GuruFocus
Wolfe Research initiates coverage on Corcept Therapeutics stock with Peerperform rating - Investing.com Canada
Using data models to predict Corcept Therapeutics Incorporated stock movement2025 Market Sentiment & Daily Price Action Insights - newser.com
Is Corcept Therapeutics Incorporated stock positioned well for digital economyWeekly Trade Review & High Win Rate Trade Alerts - newser.com
Finanzdaten der Corcept Therapeutics Inc-Aktie (CORT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):